drugset / Trial / NCT00757523

Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris

NCT00757523 ↗

Phase 4 Completed 382 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of two marketed products in subjects with facial acne vulgaris

Timeline

Start
2008-09-10
Primary completion
2009-04-24
Completion
2009-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Duac Gel Unknown 1 % Topical
Subject Duac Gel Unknown 5 % Topical
Comparator Epiduo Gel Unknown 0.1 % Topical
Comparator Epiduo Gel Unknown 2.5 % Topical

Indications